Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

Source:http://linkedlifedata.com/resource/pubmed/id/9607566

Download in:

View as

General Info

PMID
9607566